Main Management ETF Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,429,000
| Closed | -$62.2M | – | 148 |
|
|
2024
Q3 | $62.2M | Sell |
2,429,000
-325,610
| -12% | -$8.34M | 2.95% | 9 |
|
|
2024
Q2 | $64.7M | Buy |
2,754,610
+62,470
| +2% | +$1.47M | 3.23% | 12 |
|
|
2024
Q1 | $77.4M | Buy |
2,692,140
+79,475
| +3% | +$2.29M | 4.09% | 11 |
|
|
2023
Q4 | $85.7M | Buy |
2,612,665
+2,121,160
| +432% | +$69.6M | 5.03% | 7 |
|
|
2023
Q3 | $7.8M | Buy |
491,505
+222,325
| +83% | +$3.53M | 0.55% | 21 |
|
|
2023
Q2 | $9.18M | Buy |
269,180
+21,930
| +9% | +$748K | 0.66% | 21 |
|
|
2023
Q1 | $7.44M | Buy |
247,250
+49,710
| +25% | +$1.49M | 0.63% | 23 |
|
|
2022
Q4 | $5.58M | Buy |
197,540
+9,545
| +5% | +$269K | 0.52% | 20 |
|
|
2022
Q3 | $6.18M | Buy |
187,995
+3,735
| +2% | +$123K | 0.71% | 19 |
|
|
2022
Q2 | $5.8M | Buy |
184,260
+40,935
| +29% | +$1.29M | 0.64% | 19 |
|
|
2022
Q1 | $6.58M | Buy |
143,325
+49,825
| +53% | +$2.29M | 0.61% | 20 |
|
|
2021
Q4 | $5.73M | Buy |
93,500
+12,250
| +15% | +$750K | 0.5% | 22 |
|
|
2021
Q3 | $6.07M | Buy |
81,250
+3,750
| +5% | +$280K | 0.61% | 22 |
|
|
2021
Q2 | $7.17M | Buy |
77,500
+7,010
| +10% | +$648K | 0.75% | 19 |
|
|
2021
Q1 | $6.26M | Buy |
+70,490
| New | +$6.26M | 0.74% | 18 |
|